Kirstin Thelen
Kirstin Thelen publishes mostly in Pharmaceutical Science, Hematology and Internal Medicine, on topics such as Blood Coagulation and Thrombosis Mechanisms, Venous Thromboembolism Diagnosis and Management and Drug Solubulity and Delivery Systems.
- World rank
- #295,675 of 7,710,434 ranked researchers
- Rank in Germany
- #14,789 of 364,343
- Works
- 34
- Citations
- 2.2k
- Citations per work
- 66.1
What does Kirstin Thelen research?
Kirstin Thelen's work is mostly in Medicine (40%), Pharmacology, Toxicology and Pharmaceutics (21%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1440.0%
- Medicine1440.0%
- Everything else1339.0%
- Life Sciences721.0%
- 1Pharmaceutical Science16% of their works
- 2Hematology15% of their works
- 3Internal Medicine12% of their works
- 4Cardiology and Cardiovascular Medicine8% of their works
- 5Oncology5% of their works
- 6Pharmacology5% of their works
Research topics
- Blood Coagulation and Thrombosis Mechanisms
- Venous Thromboembolism Diagnosis and Management
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Pharmacogenetics and Drug Metabolism
- Drug Transport and Resistance Mechanisms
- Atrial Fibrillation Management and Outcomes
- Antibiotics Pharmacokinetics and Efficacy
Which keywords describe Kirstin Thelen's research?
The keywords of their largest research topics: Antithrombotic Therapy, Protease-Activated Receptors, Thrombin, Pulmonary Embolism, Venous Thromboembolism, Cyclodextrins, Solid Dispersions and Chitosan.
- Atrial Fibrillation
- Antibiotic Pharmacokinetics
- Multidrug Resistance
- ATP-dependent Transporters
- Chitosan
- Cyclodextrins
- Pulmonary Embolism
- Protease-Activated Receptors
- Antithrombotic Therapy
- Thrombin
- Venous Thromboembolism
- Solid Dispersions
- Nanoparticles
- Cytochrome P450
- Pharmacogenetics
- Anticoagulant Therapy
- Critically Ill Patients
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Antithrombotic Therapy252 topics
- Protease-Activated Receptors131 topic
- Thrombin131 topic
- Pulmonary Embolism121 topic
- Venous Thromboembolism121 topic
- Cyclodextrins101 topic
- Solid Dispersions101 topic
- Chitosan61 topic
- Nanoparticles61 topic
- ATP-dependent Transporters51 topic
- Cytochrome P45051 topic
- Multidrug Resistance51 topic
- Pharmacogenetics51 topic
- Antibiotic Pharmacokinetics41 topic
- Anticoagulant Therapy41 topic
- Atrial Fibrillation41 topic
- Critically Ill Patients41 topic
Where does Kirstin Thelen work?
Kirstin Thelen's main affiliation in the publication record is Bayer (Germany), Germany.
How many publications and citations does Kirstin Thelen have?
OpenAlex counts 34 works and 2,249 citations for Kirstin Thelen, an h-index of 23, ranking #295,675 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kirstin Thelen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.